NeuroOne Medical Technologies Corporation (NMTC) Free cash flow 2019–2025
NeuroOne Medical Technologies Corporation (NMTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.9MFY2025 · since FY2019: -$5.5M → -$2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.9M | +73.8% |
| FY2024 | -$11.1M | +16.1% |
| FY2023 | -$13.3M | -70.3% |
| FY2022 | -$7.8M | +10.1% |
| FY2021 | -$8.7M | -144.4% |
| FY2020 | -$3.5M | +35.0% |
| FY2019 | -$5.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross profitNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →